Citadel Advisors
SLXNW

Citadel Advisors’s Silexion Therapeutics Corp Warrant SLXNW Stock Holding History

Citadel Advisors’s Portfolio SLXNW Stock Details SLXNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,580
Closed -$456 – 7146
2024
Q4 		$456 Sell
13,580
-4,825
-26% -$162 ﹤0.01% 5866
2024
Q3 		$583 Buy
+18,405
New +$583 ﹤0.01% 5651